Summary
CHEK Chart
Check-Cap Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $3 | $3 | - | - |
| AFI Aviso Financial Inc. Aviso Financial Inc. | 100 | $212 | $212 | - | - |
Check-Cap Ltd. (CHEK) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Check-Cap Ltd. Profile
| Professional Services Industry | Industrials Sector | David Lontini CEO | NASDAQ (CM) Exchange | M2361E203 CUSIP |
| IL Country | 85 Employees | - Last Dividend | 25 Nov 2022 Last Split | 19 Feb 2015 IPO Date |
Overview
Check-Cap Ltd. stands as a pioneering entity in the medical diagnostics industry, specifically focusing on the development of innovative, non-invasive screening technologies. Based in Isfiya, Israel, and established in 2004, the company dedicates its efforts to the clinical stage advancement of a unique capsule-based system. This technology employs ultra-low-dose X-rays to meticulously scan the colon's inner lining for precancerous polyps and other structural abnormalities. This approach marks a significant stride toward early detection and prevention of colorectal cancer, aligning with the global need for more accessible and less invasive screening methods.
Products and Services
Check-Cap Ltd.'s product portfolio is centered around the C-Scan system, a ground-breaking advancement in the field of colorectal cancer screening. The C-Scan system comprises:
- C-Scan Cap: This is the core of the screening technology – an ingestible, capsule-based device designed to perform an X-ray scan of the colon. Engineered for comfort and safety, the C-Scan Cap navigates through the gastrointestinal tract, capturing high-resolution images to identify suspected polyps and other abnormalities. Its utilization of ultra-low-dose X-rays encapsulates a pivotal innovation in minimizing radiation exposure while ensuring diagnostic efficacy.
- C-Scan Track: Complementing the C-Scan Cap, the C-Scan Track is a disposable tracking system that is securely attached to the patient's back. It employs biocompatible adhesive skin patches to stay in place throughout the procedure. This component is crucial for accurately monitoring the capsule's position within the colon, facilitating precise imaging and data collection. The non-invasiveness and patient-friendly design of the C-Scan Track underscore Check-Cap's commitment to enhancing the screening experience.
- C-Scan View software: The technological ecosystem of the C-Scan system is completed by the C-Scan View software, a sophisticated client/server-based application. It plays a pivotal role in managing the screening process by enabling the procedure data download from the C-Scan Track, performing comprehensive data analysis, and generating detailed reports. This software embodies the integration of advanced computing in medical diagnostics, pushing the boundaries of accuracy, and efficiency in colorectal cancer screening.
